From Wikipedia, the free encyclopediaJump to navigation Jump to search
|Chemical and physical data|
|Molar mass||370.496 g·mol−1|
|3D model (JSmol)|
CUMYL-CB-MEGACLONE (CUMYL-CBMGACLONE, SGT-273) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in April 2020.